NASDAQ:APVO
Aptevo Therapeutics
- Stock
Last Close
1.47
06/11 22:27
Market Cap
2.78M
Beta: 5.32
Volume Today
406.93K
Avg: 60.96K
PE Ratio
0.07
PFCF: −0.27
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 18.97M - | 13.48M 28.95% | 3.83M 71.56% | 1.41M 63.31% | 3.96M 181.69% | 5.46M 37.83% | 3.93M 27.99% | 2.33M 40.84% | 785.50K 66.24% | ||
average payables | 10.78M - | 5.04M 53.22% | 5.84M - | 12.36M 111.76% | 6.52M 47.22% | 1.75M - | |||||
average receivables | 11.48M - | 6.06M 47.23% | 3.21M 46.97% | 3.68M 14.57% | 6.12M 66.31% | 4.70M 23.29% | 3.02M 35.76% | 3.08M 2.17% | 1.25M 59.44% | ||
book value per share | 66.99 - | 62.75 6.33% | 34.98 44.26% | 53.83 53.90% | 18.92 64.85% | 4.06 78.54% | 4.89 20.55% | 0.26 94.70% | 3.52 1,258.62% | ||
capex per share | -0.70 - | -1.08 54.40% | -1.74 60.70% | -0.92 47.05% | -0.61 33.99% | -0.05 91.36% | -0.03 50.52% | -0.15 486.06% | -0.01 96.26% | ||
capex to depreciation | -0.49 - | -0.53 7.34% | -0.75 42.24% | -0.45 39.99% | -0.41 8.92% | -0.07 83.24% | -0.06 8.57% | -0.62 895.79% | -0.03 94.84% | ||
capex to operating cash flow | 0.02 - | 0.03 48.85% | 0.07 117.60% | 0.03 50.51% | 0.02 43.72% | 0.00 80.98% | 0.00 16.85% | 0.03 995.73% | 0.00 95.81% | ||
capex to revenue | -0.02 - | -0.05 109.68% | -0.07 51.71% | -0.10 38.73% | -0.04 55.76% | -0.00 88.85% | -0.02 332.79% | -0.06 184.03% | -0.01 83.94% | ||
cash per share | 2.54 - | 3.28 29.06% | 37.72 1,048.67% | 53.01 40.55% | 19.06 64.04% | 4.27 77.61% | 11.79 176.28% | 9.61 18.50% | 4.44 53.81% | ||
days of inventory on hand | 395.79 - | 438.05 10.68% | 100.21 77.12% | 74.89 25.26% | 58.10 22.42% | 112.45 93.54% | |||||
days payables outstanding | 257.62 - | 217.37 15.62% | 379.87 - | 238.91 37.11% | |||||||
days sales outstanding | 121.02 - | 85.08 29.70% | 42.92 49.55% | 53.31 24.22% | 82.60 54.93% | 79.05 4.30% | 200.67 153.86% | 108.80 45.78% | 293.03 169.33% | ||
debt to assets | 0.05 - | 0.05 6.59% | 0.20 303.90% | 0.16 18.60% | 0.29 75.33% | 0.43 52.02% | 0.51 17.91% | 0.30 42.32% | 0.28 5.63% | 0.22 22.04% | |
debt to equity | 0.07 - | 0.06 6.53% | 0.36 478.19% | 0.23 36.09% | 0.63 172.87% | 1.96 208.87% | 1.65 15.64% | 13.75 732.05% | 0.53 96.14% | 0.44 16.75% | |
dividend yield | 0.28 - | ||||||||||
earnings yield | -0.32 - | -0.38 16.05% | -2.28 506.99% | 0.08 103.39% | -1.88 2,537.47% | -1.51 19.52% | -0.15 90.18% | -0.74 398.72% | 3.61 587.10% | ||
enterprise value | 154.58M - | 153.53M 0.68% | 58.09M 62.16% | 102.43M 76.32% | 17.22M 83.19% | 37.49M 117.74% | 111.71M 197.97% | 8.57M 92.33% | -1.27M 114.80% | -11.51M 808.01% | |
enterprise value over ebitda | -3.14 - | -2.65 15.60% | 3.02 213.90% | -2.10 169.45% | -0.35 83.33% | -0.97 177.05% | -4.40 354.49% | -0.40 90.90% | 0.02 104.88% | 0.40 1,941.33% | |
ev to operating cash flow | -3.29 - | -3.15 4.25% | -1.58 49.95% | -2.46 56.34% | -0.33 86.41% | -0.88 164.18% | -3.81 330.75% | -0.40 89.63% | 0.06 115.26% | 0.98 1,527.29% | |
ev to sales | 3.39 - | 4.57 34.89% | 1.59 65.11% | 6.99 338.27% | 0.75 89.32% | 1.16 54.90% | 25.93 2,142.13% | 0.70 97.31% | -0.41 158.40% | ||
free cash flow per share | -33.99 - | -35.61 4.77% | -27.24 23.51% | -28.20 3.54% | -32.60 15.61% | -14.58 55.27% | -8.67 40.53% | -4.78 44.92% | -4.13 13.59% | ||
free cash flow yield | -0.30 - | -0.32 4.77% | -0.80 150.78% | -0.48 40.42% | -1.83 285.99% | -1.59 13.28% | -0.24 85.12% | -0.61 156.50% | -1.78 193.13% | ||
graham net net | -1.14 - | -2.24 96.65% | 13.67 709.86% | 31.45 130.04% | -1.02 103.26% | -7.12 595.83% | 2.12 129.78% | -1.29 160.85% | 1.78 237.52% | ||
graham number | 233.58 - | 243.52 4.26% | 247.38 1.58% | 74.44 69.91% | 119.25 60.19% | 35.59 70.16% | 24.48 31.23% | 5.83 76.17% | 25.76 341.69% | ||
income quality | 0.92 - | 0.82 10.61% | 0.33 60.11% | -5.96 1,918.18% | 0.96 116.06% | 1.05 9.40% | 1.65 57.63% | 0.76 53.88% | -2.62 443.77% | 0.67 125.72% | |
intangibles to total assets | 0.63 - | 0.65 3.74% | 0.16 75.67% | 0.05 67.16% | 0.08 49.69% | 0.08 6.40% | 0 100% | 0 | 0 | 0 | |
interest coverage | 0.80 - | ||||||||||
interest debt per share | 4.51 - | 3.95 12.45% | 12.72 222.29% | 12.51 1.64% | 12.00 4.10% | 7.95 33.72% | 8.08 1.69% | 3.57 55.90% | -5.12 243.63% | ||
inventory turnover | 0.92 - | 0.83 9.65% | 3.64 337.14% | 4.87 33.80% | 6.28 28.91% | 3.25 48.33% | |||||
invested capital | 0.07 - | 0.06 6.53% | 0.36 478.19% | 0.23 36.09% | 0.63 172.87% | 1.96 208.87% | 1.65 15.64% | 13.75 732.05% | 0.53 96.14% | 0.44 16.75% | |
market cap | 158.17M - | 158.17M 0% | 49.38M 68.78% | 90.46M 83.18% | 28.58M 68.41% | 26.75M 6.39% | 124.28M 364.60% | 36.89M 70.31% | 11.83M 67.93% | ||
net current asset value | 16.19M - | 11.30M 30.22% | 30.12M 166.66% | 60.11M 99.56% | 11.60M 80.70% | -11.57M 199.74% | 10.31M 189.11% | -2.81M 127.30% | 11.21M 498.19% | 6.45M 42.50% | |
net debt to ebitda | 0.07 - | 0.08 9.67% | 0.45 465.24% | -0.24 154.13% | 0.23 194.15% | -0.28 220.35% | 0.49 278.41% | 1.32 167.50% | 0.20 84.76% | 0.40 97.48% | |
net income per share | -36.19 - | -42.00 16.05% | -77.76 85.13% | 4.58 105.88% | -33.41 830.09% | -13.87 58.49% | -5.44 60.76% | -5.83 7.09% | 8.37 243.59% | ||
operating cash flow per share | -33.29 - | -34.53 3.73% | -25.50 26.15% | -27.28 6.99% | -32.00 17.29% | -14.53 54.59% | -8.65 40.49% | -4.62 46.51% | -4.12 10.87% | ||
payables turnover | 1.42 - | 1.68 18.52% | 0.96 - | 1.53 59.01% | |||||||
receivables turnover | 3.02 - | 4.29 42.25% | 8.50 98.23% | 6.85 19.50% | 4.42 35.46% | 4.62 4.49% | 1.82 60.61% | 3.35 84.44% | 1.25 62.87% | ||
research and ddevelopement to revenue | 1.02 - | 1.03 1.22% | 0.81 21.61% | 1.98 144.38% | 1.53 22.52% | 0.76 50.21% | 4.14 442.47% | 1.55 62.70% | 5.74 271.62% | ||
return on tangible assets | -1.14 - | -1.51 32.10% | -1.45 3.65% | 0.06 104.32% | -0.86 1,472.16% | -0.83 4.28% | -0.34 58.27% | -0.48 40.07% | 1.25 358.43% | -0.75 160.20% | |
revenue per share | 32.31 - | 23.79 26.36% | 25.20 5.92% | 9.62 61.84% | 14.35 49.22% | 11.12 22.56% | 1.27 88.57% | 2.62 106.34% | 0.61 76.71% | ||
roe | -0.54 - | -0.67 23.89% | -2.22 232.13% | 0.09 103.82% | -1.77 2,177.33% | -3.42 93.44% | -1.11 67.45% | -22.46 1,920.40% | 2.37 110.57% | -1.53 164.28% | |
roic | -0.50 - | -0.63 24.46% | -1.62 158.25% | -0.31 80.79% | -1.00 221.58% | -1.00 0.23% | -0.35 64.73% | -1.03 191.54% | -5.19 402.99% | -1.25 75.81% | |
sales general and administrative to revenue | 3.24 - | 1.20 63.07% | 4.46 272.58% | ||||||||
shareholders equity per share | 66.99 - | 62.75 6.33% | 34.98 44.26% | 53.83 53.90% | 18.92 64.85% | 4.06 78.54% | 4.89 20.55% | 0.26 94.70% | 3.52 1,258.62% | ||
stock based compensation to revenue | 0.02 - | 0.03 39.98% | 0.10 217.33% | 0.33 218.71% | 0.09 72.16% | 0.05 46.88% | 0.29 490.96% | 0.13 54.11% | 0.58 332.93% | ||
tangible asset value | 19.39M - | 15.47M 20.19% | 36.03M 132.84% | 75.95M 110.80% | 25.16M 66.88% | 7.42M 70.50% | 16.59M 123.58% | 1.22M 92.67% | 17.97M 1,378.13% | 12.22M 32.01% | |
tangible book value per share | 13.73 - | 10.96 20.19% | 24.92 127.45% | 49.84 99.97% | 15.65 68.60% | 2.54 83.74% | 4.89 92.33% | 0.26 94.70% | 3.52 1,258.62% | ||
working capital | 21.72M - | 15.19M 30.05% | 51.87M 241.45% | 76.57M 47.63% | 31.08M 59.41% | -8.24M 126.53% | 32.73M 496.96% | 17.81M 45.57% | 18.74M 5.23% | 11.84M 36.82% |
All numbers in USD (except ratios and percentages)